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PDTHeavy atom substituted Bodipy compounds, unlike the parent chromophore, undergo rapid intersystem
crossing to generate singlet oxygen, which is the primary cytotoxic agent exploited in PDT. In this work,
we show that an organic soluble calix[4]arene can be functionalized by Knoevenagel reaction and then
converted into an amphiphilic photosensitizer in a few steps. In addition to generating a potentially use-
ful photosensitizer, the sequence of reactions is the ﬁrst use of a Bodipy dye as a chromophoric/ﬂuoro-
genic label without the typical reactive functional groups.
 2013 Elsevier Ltd. All rights reserved.Photodynamic therapy (PDT) is a non-invasive or moderately
invasive alternative to more traditional therapeutic methodologies
such as surgery, chemotherapy, and radiation therapy.1 Photody-
namic therapy has a built in selectivity, as the cytotoxic action is
contingent upon the presence of the three components at the same
spatiotemporal coordinates, namely, light, sensitizer, and dissolved
oxygen. Consequently, by controlling the region of irradiation,
some regioselectivity can be achieved.
Recent years have witnessed a growing interest in the out-
of-the-box proposals for generating and controlling the photody-
namic action.2 At the same time, novel chromophore families have
been introduced as potential sensitizers.3 Bodipy dyes have
emerged as a promising class,4 in part, due to our contributions
highlighting the chemistry5 and singlet oxygen generation capac-
ity6 of these compounds. Bodipy dyes were previously recognized
as chemically and photochemically stable chromophores, and part
of this stability was ascribed to the inaccessibility of the triplet
manifold, thus reducing the chances of potential degradative inter-
actions with ambient oxygen. However, Bodipy dyes can be trans-
formed into efﬁcient photosensitizers by the incorporation of
heavy atoms4d or by increasing the degeneracy of the excited state
frontier orbitals.6
Another matter of concern is the wavelength of irradiation.
Current PDT practice makes use of porphyrins or closely related
derivatives.1,7 These dyes have relatively weak absorptions in thered part of the visible spectrum where mammalian tissues are
most transparent.4b Therefore, the ever existing drive to obtain
dyes with strong absorptions in the red and near IR region of the
spectrum is understandable.
Bodipy dyes are likely to evolve into satisfactory alternatives to
the traditional core of sensitizers. The absorption bands of the
Bodipy dyes are highly tunable. In particular, in those with styryl
substitution, the absorption peak can be located anywhere from
500 to 850 nm.4b,5c,8
With these considerations, we designed compound 5 as the tar-
get molecule (Fig. 1). The synthesis started with a partially
tert-butylated calixarene derivative 1. This compound can be
obtained in three steps from commercially available compounds
starting from the most common entry point to the calixarene
chemistry, tetrakis-tert-butylcalix[4]arene,9 following literature
precedence10 (detailed reaction steps can be found in the
Supplementary data). Reﬂuxing compound 1 with 1-bromodecane
in acetonitrile in the presence of anhydrous potassium carbonate
yielded the tetradecylated product in frozen cone conformation.
Subsequent formylation in TFA with hexamethylenetetramine
(HMTA) at an elevated temperature yielded the key intermediate
2 as the major product (99% yield).
Intermediate 3 was reported in earlier work5a and under
Knoevenagel condensation conditions reacted with 2 to form a
monocondensation product. This reaction is an interesting demon-
stration of the versatility of the Bodipy chromophore. Thus, two
Bodipy dyes were successfully attached to the upper rim of the
calix[4]arene. A second condensation reaction, this time with
Figure 2. Time course of the decomposition of trap molecules upon irradiation with
a 725 nm LED array in the absence (black squares) and presence (red circles) of 5; in
IPA using an organic soluble trap molecule, 1,3-diphenyl-iso-benzofuran (DPBF)
with (red circles) and without (black squares) 46 nM sensitizer 5 (top); in PBS buffer
(pH 7.4) using the water soluble trap molecule, 2,20-[anthracene-9,10-diylbis(meth-
ylene)]-dimalonic acid (ADMDA) with (red circles) and without (black squares)
2.3 lM sensitizer 5 (bottom). For the ﬁrst 15 min the light source was turned off
and then turned on.
Figure 1. The structure of the targeted calix-Bodipy photosensitizer, 5.
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extended conjugation pushes the main absorption band corre-
sponding to the S0–S1 transition from red to near infrared wave-
lengths (725 nm in PBS solution, Fig. S3). In the ﬁnal step, an
azide–alkyne Huisgen cycloaddition reaction was carried out un-
der standard conditions with methoxypolyethyleneglycol azide
(MW = 2000 g/mol).5a The reaction proceeded smoothly to yield a
water soluble, yet amphiphilic derivative 5 which was expected
to be a potent photosensitizer by design (Scheme 1). Thus, two
Bodipy units were tethered to the calix[4]arene and this reaction
extends the conjugation such that the absorption of the Bodipy
dye is within the so-called ‘therapeutic window’. The Bodipy core
was previously assembled on the calixarene lower rim,11 but this
is the ﬁrst time a fully formed Bodipy unit is conjugated to a calix-
arene through a Knoevenagel reaction.
The electronic absorption spectrum of the sensitizer shows a
strong peak at 725 nm in aqueous solutions, with an extinction
coefﬁcient of 130,000 M1 cm1. Thus, the compound is clearly a
strong near infrared absorber.
The singlet oxygen generation capacity of the target compound
was studied in both organic and aqueous solutions. For assessing
activity in organic solutions, 1,3-diphenyl-iso-benzofuran (DPBF)
was used as a trap (Fig. 2, top). In a typical experiment, 46 nM ofScheme 1. Synthesis of the calix-Bodipy photosensitizer, 5: Reagents and conditions: (a) C10H21Br, NaH, DMF, 60 C, 12 h; (b) HMTA, TFA, 125 C, 4 h; (c) 2, AcOH, piperidine,
C6H6, reﬂux (Dean–Stark); (d) 4-(dimethylamino)benzaldehyde, AcOH, piperidine, C6H6, reﬂux (Dean–Stark); (e) PEG-N3 (MW = 2000), CuI, DMF, 60 C, overnight.
Figure 3. The change in the absorption spectrum as singlet oxygen is produced by
sensitization in aqueous solution. ADMDA in the presence of 5 (2.3 lM) in PBS
solution (pH 7.4) was kept in the dark (15 min, no change, overlapping traces) and
under near IR irradiation (at 725 nm for 60 min).
Figure 4. The structure and singlet oxygen reaction of the water-soluble 1O2
scavenger molecule 2,20-[anthracene-9,10-diylbis(methylene)]dimalonic acid
(ADMDA). Absorbance due to the anthracene core diminishes as the reaction
progresses.
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10 lM was subjected to irradiation from a 725 nm LED array. As
expected, without the sensitizer, the absorption band due to DPBF
did not change over time on near IR irradiation (black line). How-
ever, in the presence of the photosensitizer 5, the degradation
started immediately once the LED array had been turned on
(red line). In addition, a control experiment without light and with
sensitizer was performed in the ﬁrst 15 min of the experiment; no
decrease in the absorbance of the trap molecule was observed,
thereby eliminating any possibility of a dark reaction having
occurred. The intensity of the light is in fact quite weak, typically
less than 1 mW/cm2. The activity in the aqueous solutions was also
determined (Fig. 2, bottom, and Fig. 3), this time using a water sol-
uble singlet oxygen trap, 2,20-[anthracene-9,10-diylbis(methy-
lene)]dimalonic acid (see Fig. 4 for structure and reaction with
1O2), which was synthesized following a literature procedure.12
The photosensitization was then studied in an aqueous solution
comprising PBS buffer (pH 7.4) and ethanol (90/10).
The trap (1 lM) was irradiated in the presence and absence of
the photosensitizer 5. Again, the trap molecule reacted only inthe presence of the sensitizer 5 (2.3 lM). In this case too, control
experiments showed that singlet oxygen generation activity only
proceeded in the presence of the sensitizer and light.
In conclusion, we were able to functionalize calix[4]arene with
two Bodipy chromophores with strong intersystem crossing ten-
dency due to the presence of heavy iodine atoms attached to the
Bodipy core. The long chain alkyl substituents on the calixarene
lower rim provide some hydrophobic character, while the two
PEG groups aid water solubility. The result is an amphiphilic pho-
tosensitizer. Considering the fact that most successful PDT photo-
sensitizers are amphiphilic in nature, this is quite relevant. The
use of styryl substitution ensures long wavelength (near IR)
absorption. This extension of conjugation in 5 is another clear
demonstration of the versatility of Bodipy chemistry.
We are conﬁdent that calixarenes functionalized in this manner
will ﬁnd applications as potential platforms for singlet oxygen car-
riers and delivery agents.
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